Radiotracer labelled thymohydroquinyl gallate capped gold nanoparticles as theranostic radiopharmaceutical for targeted antineoplastic and bioimaging

Journal of Pharmaceutical Analysis

Available online 12 March 2024, 100965

Journal of Pharmaceutical AnalysisAuthor links open overlay panel, , , , , , , , Highlights•

Evaluation of dual antineoplastic role by combining Thymoquinone and Gallic Acid.

Bioimaging of drug biodistribution by radiolabeled prodrug composite.

Targeted delivery of prodrug conjugate to cancer cells in vitro and in vivo.

Comparative studies are carried out to assess the impact of Thymoquinone modification.

Abstract

Thymoquinone (Tq) and gallic acid (GA) are known for counter-tumorigenic characteristics. GA inhibits cancer cell proliferation by interfering with many apoptotic signaling pathways, producing more reactive oxygen species (ROS), focusing on the cell cycle, and suppressing the expression of oncogenes and matrix metalloproteinases (MMPs). In this study, thymoquinone (after reducing to thymohydroquinone) and gallic acid are esterified to form thymohydroquinyl gallate (a prodrug). Thymohydroquinyl gallate (THQG) possesses enhanced antineoplastic efficacy and targeted delivery potential. The chemical and spectroscopic analysis confirms ester synthesis. Gold nanoparticles (AuNPs) are employed as nanocarriers due to their physicochemical and optical characteristics, biocompatibility, and low toxicity. As an efficient drug transporter, gold nanoparticles (AuNPs) shield conjugated drugs from enzymatic digestion. The prodrug acts as a reducing agent for Au metal atoms and is loaded onto it after reduction. The nano drug is radiolabeled with 99mTc and 131I to monitor the drug biodistribution in animals using a gamma camera and single-photon emission computerized tomography (SPECT). 131I is an antineoplastic that helps enhance the drug's efficiency. Chromatographic results reveal promising radiolabeling percentages. In vitro, drug release shows sustained release at pH⁓5.8. In vitro 3−[4,5−dimethylthiazol−2−yl]−2,5 diphenyl tetrazolium bromide (MTT) cytotoxicity assay reveals drug potency on CAL 27 and MCF 7 cell lines.

Keywords

Cancer theranostics

Gallic acid

Gold nanoparticles

Targeted drug delivery

Thymoquinone

© 2024 Published by Elsevier B.V. on behalf of Xi’an Jiaotong University.

留言 (0)

沒有登入
gif